secwatch.observer — SEC 8-K summary
======================================

Issuer:     Glucotrack, Inc. (GCTK)
CIK:        0001506983
Form:       8-K
Filed at:   2026-08-05T21:20:30+00:00
Accession:  0001493152-26-036218
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glucotrack raises $5.5M in combined equity and convertible debt financing
-------------------------------------------------------------------------

- $2.0M equity PIPE at $0.75/unit: each unit includes one share (or pre-funded warrant) and a 5-year warrant at $1.50.
- $3.5M follow-on bridge convertible debt with 8% interest, 9-month maturity, and 22% original issue discount.
- Conversion and warrant exercise require stockholder approval; conversion price is lower of Nasdaq minimum or 80% of VWAP.
- Proceeds to strengthen balance sheet and provide growth capital for portfolio execution.
- E.F. Hutton & Co. served as exclusive advisor to Lōkahi Therapeutics, a Glucotrack subsidiary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506983/000149315226036218/0001493152-26-036218-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506983/000149315226036218/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-036218

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer